Jose L. Lopez-Ribot to Mutation
This is a "connection" page, showing publications Jose L. Lopez-Ribot has written about Mutation.
Connection Strength
0.520
-
Vila TV, Chaturvedi AK, Rozental S, Lopez-Ribot JL. In Vitro Activity of Miltefosine against Candida albicans under Planktonic and Biofilm Growth Conditions and In Vivo Efficacy in a Murine Model of Oral Candidiasis. Antimicrob Agents Chemother. 2015 Dec; 59(12):7611-20.
Score: 0.098
-
Chaturvedi AK, Lazzell AL, Saville SP, Wormley FL, Monteagudo C, Lopez-Ribot JL. Validation of the tetracycline regulatable gene expression system for the study of the pathogenesis of infectious disease. PLoS One. 2011; 6(5):e20449.
Score: 0.072
-
Lee SA, Jones J, Hardison S, Kot J, Khalique Z, Bernardo SM, Lazzell A, Monteagudo C, Lopez-Ribot J. Candida albicans VPS4 is required for secretion of aspartyl proteases and in vivo virulence. Mycopathologia. 2009 Feb; 167(2):55-63.
Score: 0.060
-
Saville SP, Thomas DP, L?pez Ribot JL. A role for Efg1p in Candida albicans interactions with extracellular matrices. FEMS Microbiol Lett. 2006 Mar; 256(1):151-8.
Score: 0.050
-
L?pez-Ribot JL. Candida albicans biofilms: more than filamentation. Curr Biol. 2005 Jun 21; 15(12):R453-5.
Score: 0.048
-
Li X, Brown N, Chau AS, L?pez-Ribot JL, Ruesga MT, Quindos G, Mendrick CA, Hare RS, Loebenberg D, DiDomenico B, McNicholas PM. Changes in susceptibility to posaconazole in clinical isolates of Candida albicans. J Antimicrob Chemother. 2004 Jan; 53(1):74-80.
Score: 0.043
-
Ramage G, Bachmann S, Patterson TF, Wickes BL, L?pez-Ribot JL. Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms. J Antimicrob Chemother. 2002 Jun; 49(6):973-80.
Score: 0.039
-
Banerjee M, Lazzell AL, Romo JA, Lopez-Ribot JL, Kadosh D. Filamentation Is Associated with Reduced Pathogenicity of Multiple Non-albicans Candida Species. mSphere. 2019 10 16; 4(5).
Score: 0.032
-
Thomas DP, Lopez-Ribot JL, Lee SA. A proteomic analysis of secretory proteins of a pre-vacuolar mutant of Candida albicans. J Proteomics. 2009 Dec 01; 73(2):342-51.
Score: 0.016
-
Banerjee M, Thompson DS, Lazzell A, Carlisle PL, Pierce C, Monteagudo C, L?pez-Ribot JL, Kadosh D. UME6, a novel filament-specific regulator of Candida albicans hyphal extension and virulence. Mol Biol Cell. 2008 Apr; 19(4):1354-65.
Score: 0.014
-
P?rez A, Pedr?s B, Murgui A, Casanova M, L?pez-Ribot JL, Mart?nez JP. Biofilm formation by Candida albicans mutants for genes coding fungal proteins exhibiting the eight-cysteine-containing CFEM domain. FEMS Yeast Res. 2006 Nov; 6(7):1074-84.
Score: 0.013
-
Chamilos G, Lionakis MS, Lewis RE, Lopez-Ribot JL, Saville SP, Albert ND, Halder G, Kontoyiannis DP. Drosophila melanogaster as a facile model for large-scale studies of virulence mechanisms and antifungal drug efficacy in Candida species. J Infect Dis. 2006 Apr 01; 193(7):1014-22.
Score: 0.013
-
Ullmann BD, Myers H, Chiranand W, Lazzell AL, Zhao Q, Vega LA, Lopez-Ribot JL, Gardner PR, Gustin MC. Inducible defense mechanism against nitric oxide in Candida albicans. Eukaryot Cell. 2004 Jun; 3(3):715-23.
Score: 0.011
-
Perea S, L?pez-Ribot JL, Kirkpatrick WR, McAtee RK, Santill?n RA, Mart?nez M, Calabrese D, Sanglard D, Patterson TF. Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients. Antimicrob Agents Chemother. 2001 Oct; 45(10):2676-84.
Score: 0.009